Analyte flux at a biomaterial-tissue interface over time: Implications for sensors for type 1 and 2 diabetes mellitus

Journal of Diabetes Science and Technology

Volumn 4, Issue 5, 2010, Pages 1063-1072

  Ekberg, Neda Rajamand ^a   Brismar, Kerstin ^a   Malmstedt, Jonas ^a   Hedblad, Mari Anne ^b   Adamson, Ulf ^c   Ungerstedt, Urban ^a   Wisniewski, Natalie ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

^d Medical Device Consultancy   (United States)

Author keywords

Biosensors; Diabetes mellitus; Foreign body response; Glucose metabolism; Material tissue interaction; Microdialysis

Indexed keywords

BIOMATERIAL; GLUCOSE; GLYCEROL; LACTIC ACID DERIVATIVE; PYRUVIC ACID DERIVATIVE; UREA;

ADULT; AGED; ARTICLE; BIOPSY; CHEMISTRY; COMPARATIVE STUDY; FOREIGN BODY; GENETIC PROCEDURES; HUMAN; INFLAMMATION; INSTRUMENTATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; METABOLISM; METHODOLOGY; MIDDLE AGED; MITOCHONDRION; MONITORING; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PHYSIOLOGY; SKIN;

ADULT; AGED; BIOCOMPATIBLE MATERIALS; BIOPSY; BIOSENSING TECHNIQUES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FOREIGN BODIES; GLUCOSE; GLYCEROL; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LACTATES; MIDDLE AGED; MITOCHONDRIA; MONITORING, PHYSIOLOGIC; PYRUVATES; SKIN; UREA;

EID: 79952199414     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400505     Document Type: Conference Paper

References (49)

1. Reichard P, Britz A, Carlsson P, Cars I, Lindblad L, Nilsson BY, Rosenqvist U. Metabolic control and complications over 3 years in patients with insulin dependent diabetes (IDDM): the Stockholm Diabetes Intervention Study (SDIS). J Intern Med. 1990;228(5):511-7.
2. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet. 1993;341(8856):1306-9.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-53.
4. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-65.
5. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643-53.
6. Klueh U, Liu Z, Ouyang T, Cho B, Feldman B, Henning TP, Kreutzer D. Blood-induced interference of glucose sensor function in vitro: implications for in vivo sensor function. J Diabetes Sci Technol. 2007;1(6):842-9.
7. Cunningham DD, Stenken JA. In vivo glucose sensing. Hoboken: Wiley; 2010.
8. Wisniewski N, Reichert M. Methods for reducing biosensor membrane biofouling. Colloids Surf B Biointerfaces. 2000;18(3-4):197-219.
9. Wisniewski N, Moussy F, Reichert WM. Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem. 2000;366(6-7):611-21.
10. Ungerstedt U. Microdialysis - principles and applications for studies in animals and man. J Intern Med. 1991;230(4):365-73.
11. Mou X, Stenken JA. Microdialysis sampling extraction efficiency of 2-deoxyglucose: role of macrophages in vitro and in vivo. Anal Chem. 2006;78(22):7778-84.
12. Wisniewski N, Klitzman B, Miller B, Reichert WM. Decreased analyte transport through implanted membranes: differentiation of biofouling from tissue effects. J Biomed Mater Res. 2001;57(4):513-21.
13. Arvidsson E, Viguerie N, Andersson I, Verdich C, Langin D, Arner P. Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes. 2004;53(8):1966-71.
14. Langin D. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res. 2006;53(6):482-91.
15. Lutgers HL, Hullegie LM, Hoogenberg K, Sluiter WJ, Dullaart RP, Wientjes KJ, Schoonen AJ. Microdialysis measurement of glucose in subcutaneous adipose tissue up to three weeks in type 1 diabetic patients. Neth J Med. 2000;57(1):7-12.
16. Wientjes KJ, Vonk P, Vonk-van Klei Y, Schoonen AJ, Kossen NW. Microdialysis of glucose in subcutaneous adipose tissue up to 3 weeks in healthy volunteers. Diabetes Care. 1998;21(9):1481-8.
17. Wisniewski N, Rajamand N, Adamsson U, Lins PE, Reichert WM, Klitzman B, Ungerstedt U. Analyte flux through chronically implanted subcutaneous polyamide membranes differs in humans and rats. Am J Physiol Endocrinol Metab. 2002;282(6):E1316-23.
18. Ekberg NR, Wisniewski N, Brismar K, Ungerstedt U. Measurement of glucose and metabolites in subcutaneous adipose tissue during hyperglycemia with microdialysis at various perfusion flow rates. Clin Chim Acta. 2005;359(1-2):53-64.
19. Huijberts MS, Schaper NC, Schalkwijk CG. Advanced glycation end products and diabetic foot disease. Diabetes Metab Res Rev. 2008;24 Suppl 1:S19-24.
20. Markuson M, Hanson D, Anderson J, Langemo D, Hunter S, Thompson P, Paulson R, Rustvang D. The relationship between hemoglobin A(1c) values and healing time for lower extremity ulcers in individuals with diabetes. Adv Skin Wound Care. 2009;22(8):365-72.
21. Marston WA, Dermagraft Diabetic Foot Ulcer Study Group. Risk factors associated with healing chronic diabetic foot ulcers: the importance of hyperglycemia. Ostomy Wound Manage. 2006;52(3):26-8.
22. Ortega Martinez de Victoria E, Xu X, Koska J, Francisco AM, Scalise M, Ferrante AW Jr, Krakoff J. Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians. Diabetes. 2009;58(2):385-93.
23. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796-808.
24. Hehenberger K, Heilborn JD, Brismar K, Hansson A. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate. Wound Repair Regen. 1998;6(2):135-41.
25. Hehenberger K, Hansson A, Heilborn JD, Abdel-Halim SM, Ostensson CG, Brismar K. Impaired proliferation and increased L-lactate production of dermal fibroblasts in the GK-rat, a spontaneous model of non-insulin dependent diabetes mellitus. Wound Repair Regen. 1999;7(1):65-71.
26. Liu D, Moberg E, Wredling R, Lins PE, Adamson U. Insulin absorption is faster when keeping the infusion site in use for three days during continuous subcutaneous insulin infusion. Diabetes Res Clin Pract. 1991;12(1):19-24.
27. Swan KL, Dziura JD, Steil GM, Voskanyan GR, Sikes KA, Steffen AT, Martin ML, Tamborlane WV, Weinzimer SA. Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care. 2009 Feb;32(2):240-4.
28. Kim PK, Deutschman CS. Inflammatory responses and mediators. Surg Clin North Am. 2000;80(3):885-94.
29. Brauker JH, Carr-Brendel VE, Martinson LA, Crudele J, Johnston WD, Johnson RC. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res. 1995;29(12):1517-24.
30. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J Biomed Mater Res. 1997;37(3):401-12.
31. Contaldo C, Plock J, Djonov V, Leunig M, Banic A, Erni D. The influence of trauma and ischemia on carbohydrate metabolites monitored in hamster flap tissue. Anesth Analg. 2005;100(3):817-22.
32. Edsander-Nord A, Röjdmark J, Wickman M. Metabolism in pedicled and free TRAM flaps: a comparison using the microdialysis technique. Plast Reconstr Surg. 2002;109(2):664-73.
33. Caldwell MD, Shearer J, Morris A, Mastrofrancesco B, Henry W, Albina JE. Evidence for aerobic glycolysis in lambda-carrageenan-wounded skeletal muscle. J Surg Res. 1984;37(1):63-8.
34. Forster J, Morris AS, Shearer JD, Mastrofrancesco B, Inman KC, Lawler RG, Bowen W, Caldwell MD. Glucose uptake and flux through phosphofructokinase in wounded rat skeletal muscle. Am J Physiol. 1989;256(6 Pt 1):E788-97.
35. Klueh U, Kaur M, Qiao Y, Kreutzer DL. Critical role of tissue mast cells in controlling long-term glucose sensor function in vivo. Biomaterials. 2010;31(16):4540-51.
36. Dungel P, Long N, Yu B, Moussy Y, Moussy F. Study of the effects of tissue reactions on the function of implanted glucose sensors. J Biomed Mater Res A. 2008;85(3):699-706.
37. Koschwanez HE, Reichert WM, Klitzman B. Intravital microscopy evaluation of angiogenesis and its effects on glucose sensor performance. J Biomed Mater Res A. 2010;93(4):1348-57.
38. Guillet C, Delcourt I, Rance M, Giraudet C, Walrand S, Bedu M, Duche P, Boirie Y. Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men. J Clin Endocrinol Metab. 2009;94(8):3044-50.
39. Luzi L, Castellino P, DeFronzo RA. Insulin and hyperaminoacidemia regulate by a different mechanism leucine turnover and oxidation in obesity. Am J Physiol. 1996;270(2 Pt 1):E273-81.
40. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-6.
41. Large V, Arner P. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab. 1998;24(5):409-18.
42. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307(5708):384-7.
43. MacDonald MJ, Longacre MJ, Langberg EC, Tibell A, Kendrick MA, Fukao T, Ostenson CG. Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes. Diabetologia. 2009;52(6):1087-91.
44. Rabøl R, Boushel R, Dela F. Mitochondrial oxidative function and type 2 diabetes. Appl Physiol Nutr Metab. 2006;31(6):675-83.
45. Schummer CM, Werner U, Tennagels N, Schmoll D, Haschke G, Juretschke HP, Patel MS, Gerl M, Kramer W, Herling AW. Dysregulated pyruvate dehydrogenase complex in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab. 2008;294(1):E88-96.
46. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm. 2006;74:443-77.
47. Morino K, Petersen KF, Shulman GI. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes. 2006;55 Suppl 2:S9-15.
48. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27(3):813-23.
49. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 1998;41(10):1241-8.